Is KalVista Pharmaceuticals, Inc. (KALV) halal? Doubtful. Based on AAOIFI screening, KalVista Pharmaceuticals, Inc. passes the business activity screen but has financial ratios approaching AAOIFI limits with a compliance score of 51/100 (Grade: C+).

KalVista Pharmaceuticals, Inc.

KALV: Is KalVista Pharmaceuticals, Inc. Halal?

Doubtful

KalVista Pharmaceuticals, Inc.

NASDAQHealthcareUS

$26.77

+0.20%

Purify ~4.2% of income

Why This Stock Is Doubtful

  • Non-compliant income is 4.2% of revenue, only 0.8 points below the 5% limit

Stocks are marked Doubtful when financial ratios pass but approach AAOIFI thresholds. Consider consulting a qualified scholar for a definitive ruling.

Shariah Compliance Status

AAOIFI Standard 21Updated Jun 18, 2026
C+

Fair

Some financial ratios approaching limits

51Score

Business Activity Screen

Passed

Checks if the business is involved in prohibited activities (alcohol, gambling, pork, conventional banking, etc.)

Financial Ratio Screen

Passed

Financial ratios must be below AAOIFI thresholds

Debt / Market Cap12.0% / 30.0%

Compliance History

  1. Doubtfulnow

    since Jun 2026

  2. Halal

    until the change above

Tracked since May 2026. Updates automatically on each re-screen.

Screened: Jun 18, 2026Fiscal: Q1 2026Source: EDGAR

Purify Your KALV Dividends

4.2% non-compliant income

KALV has 4.2% prohibited income. Calculate exactly how much of your dividends to donate.

Financial Overview

Market Cap

1.4B

Price

$26.77

Sector

Healthcare

Industry

Biotechnology

Free 路 No credit card required

Track KALV and 10,000+ stocks with AI insights

Create your free account to unlock AI-powered compliance analysis, track your portfolio, calculate purification, and get unlimited AAOIFI screening.

10,000+ assets AAOIFI standards Free watchlist

Frequently Asked Questions

Is KalVista Pharmaceuticals, Inc. (KALV) halal to invest in?
KalVista Pharmaceuticals, Inc. (KALV) is rated Doubtful under AAOIFI Standard 21. It passes the business activity screen but one or more financial ratios are approaching (though not yet exceeding) the AAOIFI thresholds (30% for debt and interest deposits, 5% for prohibited income). Consult a qualified Islamic finance scholar for a personal ruling.
Why did KalVista Pharmaceuticals, Inc. get a C+ compliance rating?
KalVista Pharmaceuticals, Inc. (KALV) received a grade of C+ (Fair) based on three AAOIFI Standard 21 financial ratios: debt-to-market-cap of 12.0% (limit 30%); interest-bearing deposits of 20.9% (limit 30%); prohibited income of 4.25% (limit 5%). The grade reflects the margin of safety across all three ratios relative to their thresholds.
What could change KalVista Pharmaceuticals, Inc.'s Shariah verdict?
KalVista Pharmaceuticals, Inc.'s verdict is re-evaluated at each annual re-screen. Three events could change it: (1) the debt-to-market-cap ratio crossing 30%, typically from new debt issuance or a major drop in share price; (2) interest-bearing deposits exceeding 30% of market cap; or (3) prohibited revenue (alcohol, gambling, conventional finance, etc.) exceeding 5% of total revenue. Verdict flips are tracked in the compliance history section above.
How often is KalVista Pharmaceuticals, Inc. re-screened for Shariah compliance?
KalVista Pharmaceuticals, Inc. (KALV) is re-screened annually using the most recent full-year financial data from SEC filings. HalalScreener also triggers an on-demand re-screen whenever the stored data is more than 7 days old, ensuring the ratios reflect the latest available financial statements. Last screened: Jun 18, 2026.

Screened according to AAOIFI Standard No. 21 路 For informational purposes only. Consult a qualified Islamic finance advisor before investing.

Disclaimer: This screening is for informational purposes only and does not constitute financial, legal, or religious advice. Compliance is evaluated using AAOIFI financial standards (debt, deposits, and prohibited income ratios) and publicly available data. Ethical, political, social, or environmental considerations are outside the scope of this screening. Individual scholars and methodologies may differ. Always consult a qualified Islamic finance advisor before making investment decisions.